Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine GONB for acute migraine in the ED
NCT02665273Phase 3Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jul 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in migraine, sponsored by Montefiore Medical Center. Started Jul 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02665273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665273.